# Nevirapine Drug Levels in HIV Positive Patients Also Receiving Rifampicin for Tuberculosis

> **NCT00617643** · PHASE4 · COMPLETED · sponsor: **Makerere University** · enrollment: 18 (estimated)

## Conditions studied

- HIV Infections
- Tuberculosis

## Interventions

- **DRUG:** Nevirapine without dose escalation
- **DRUG:** Nevirapine initiation with dose escalation

## Key facts

- **NCT ID:** NCT00617643
- **Lead sponsor:** Makerere University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2009-06
- **Final completion:** 2010-12
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2010-12-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00617643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00617643, "Nevirapine Drug Levels in HIV Positive Patients Also Receiving Rifampicin for Tuberculosis". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00617643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*